AI assistant
IN8BIO, INC. — Director's Dealing 2021
Jul 30, 2021
35200_dirs_2021-07-29_7799a017-c7f1-4a65-a46c-98275ba9b273.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2021-07-29
Reporting Person: Brandt Peter C. (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 182500 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $1.0959 | 2029-08-12 | Common Stock (29664) | Direct | |
| Stock Option (right to buy) | $6.7398 | 2030-10-04 | Common Stock (42557) | Direct |
Footnotes
F1: The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT.
F2: The shares subject to the option vested or shall vest in sixteen (16) equal quarterly installments commencing October 1, 2019, subject to the Reporting Person continuing to provide service through each such date.
F3: The shares subject to the option shall vest in twelve (12) equal quarterly installments commencing January 1, 2021, subject to the Reporting Person continuing to provide service through each such date.